You are here
Amgen's new cancer drug treatment to cost US$178,000
AMGEN Inc's leukaemia drug Blincyto will cost US$178,000 for a standard course of treatment, continuing a trend of high prices for immunotherapy, the newest wave of cancer treatments.
The price includes two US$89,000 cycles of therapy, the median duration of treatment
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org